Click on headlines below to download research

Open season on Exosome deals
ReNeuron Group | 04/01/2019

Building on last year’s business development activities, ReNeuron has announced its first collaboration based on its exosome platform which was introduced…

Time to reflect
ReNeuron Group | 21/12/2018

ReNeuron’s H119 results highlighted cash of £30.7m, allowing it to execute on its ongoing clinical trials, although execution will bring a…

Exosomes rise further
ReNeuron Group | 20/07/2018

ReNeuron’s capital markets day highlighted the potential for the company’s exosome nanomedicine platform to be a source of both product and…